$0.92
-0.01 | -1.08%
-0.01 | -1.08%
Today's Range:
0.90 -
0.93
CYTK Avg. Daily Volume:
216,000
05/29/12 - 1:56 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.93 |
| 52 Week High | 1.51 |
| 52 Week Low | 0.85 |
| Avg. Daily Vol. (Mil) | 0.22 |
| Beta (3 year) | 1.66 |
| Share Related Items | |
| Mkt Cap (Mil) | 72.09 |
| Shares Out (Mil) | 77.51 |
| Float (Mil) | 72.93 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 9.70 |
| Current Ratio | 10.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 14.25 |
| Price/Book | 1.72 |
| Price/Cash Flow | -1.50 |
| Per Share Data | |
| Earnings | -0.68 |
| Sales | 0.07 |
| Book Value | 0.54 |
| Cash Flow | -0.62 |
| Business Summary | |
|---|---|
| Cytokinetics, Inc.is a clinical-stage biopharmaceutical company, which focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. | |
| General Information | |
| 280 East Grand Avenue
South San Francisc, CA 94080 |
|
| www.cytokinetics.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 79 | |
| CEO: Robert I. Blum | |
| Short Interest | |
| Current Month (Mil) | 0.54 |
| Previous Month (Mil) | 0.52 |
| Short Interest Ratio (Days) | 2.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -99.00 |
| Return on Investments | -109.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,524.42 | 1,326.72 | 2,855.25 | 17.17 |
Oil *
106.70
|
|
UP
69.59 |
UP
8.90 |
UP
17.72 |
DOWN
0.28 |
10 Yr
1.72%
SPDR Gold
150.71
|
|
+0.56%
|
+0.68%
|
+0.62%
|
-1.60%
|
Data delayed 20 minutes |
Connect with TheStreet